Repligen (RGEN) PT Lowered to $145 at Canaccord
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $126.57 --0%
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 10 | New: 17
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 10 | New: 17
Join SI Premium – FREE
Canaccord analyst Kyle Mikson lowered the price target on Repligen (NASDAQ: RGEN) to $145.00 (from $165.00) while maintaining a Hold rating.
You May Also Be Interested In
- Deutsche Bank Downgrades L'Oreal SA (OR:FP) (LRLCY) to Sell
- Osisko Metals (OM:CN) PT Raised to Cdn$3.25 at Canaccord
- Varonis Systems (VRNS) PT Raised to $40 at Needham
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
